SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-17-000052
Filing Date
2017-03-03
Accepted
2017-03-02 21:46:55
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2679520
2 filename2.htm EX-3.1 479450
3 g23580.jpg GRAPHIC 72538
4 g48232.jpg GRAPHIC 94287
5 g137232.jpg GRAPHIC 47141
6 g171998.jpg GRAPHIC 30165
7 g177033.jpg GRAPHIC 56607
8 g187702.jpg GRAPHIC 49868
9 g239568.jpg GRAPHIC 81555
10 g243477.jpg GRAPHIC 58452
11 g260881.jpg GRAPHIC 73626
12 g354214.jpg GRAPHIC 91972
13 g452874.jpg GRAPHIC 69730
14 g638402.jpg GRAPHIC 47669
15 g666819.jpg GRAPHIC 11860
16 g759153.jpg GRAPHIC 23740
17 g780495.jpg GRAPHIC 48060
18 g1027178.jpg GRAPHIC 30724
  Complete submission text file 0000912057-17-000052.txt   4384301
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01433 | Film No.: 17661383
SIC: 2834 Pharmaceutical Preparations